Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane

A.E.C.A.B. Willemsen*, X.H. He, B. van Cranenbroek, P.C. de Jong, M. de Boer, I. Joosten, H.J.P.M. Koenen, C.M.L. van Herpen, W.R. Gerritsen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number107404
Number of pages8
JournalInternational Immunopharmacology
Volume93
DOIs
Publication statusPublished - 1 Apr 2021

Keywords

  • Everolimus
  • Drug-induced lung injury
  • Interstitial lung disease
  • Immunomonitoring
  • Response prediction
  • REGULATORY T-CELLS
  • BRONCHOALVEOLAR LAVAGE FLUID
  • MTOR INHIBITOR
  • NATURAL-KILLER
  • RAPAMYCIN
  • PNEUMONITIS
  • MANAGEMENT
  • SIROLIMUS
  • EXPANSION

Cite this